Mouse Specifics, Inc. developed the ECGenie non-invasive ECG monitor for awake mice.
Public source
Publisher name
Public post
In a first-of-its-kind study, researchers at the University of Colorado Anschutz School of Medicine examined how #cancer affects the growth and function of the developin…
Company
Mouse Specifics, Inc.
"...better....& more...data from every mouse!"
- Industry
- Biotechnology Research
- Location
- Framingham, US
- Company size
- 2–10 employees
About Mouse Specifics, Inc.
Mouse Specifics Inc. (MSI) is a biotech company that develops innovative instrumentation to accelerate the translation of preclinical research to benefit human health and well-being. With tens of millions of laboratory animals used each year in biomedical research, MSI aims to provide a better experience for the animals, the researchers studying them, and the patients we hope benefit from countless pre-clinical studies. Our patented instruments include the ECGenie, a non-invasive heart monitor for awake animals, and the DigiGait Imaging System, which describes strength, balance, and coordination in animal models of human movement disorders. The ECGenie and DigiGait have application to numerous disease areas, such as CNS disorders, pain, and neuro-degenerative diseases. Our customers include academic institutions, biotechnology companies, and large pharmaceutical companies, domestic and abroad. The demand for our elegantly efficient in vivo technologies is rapidly growing. For more information, visit www.mousespecifics.com. Customers include: Harvard Medical School Icahn School of Medicine at Mount Sinai- New York Medical University of South Carolina National Institute of Health Pfizer Texas A&M University University of Kansas Medical Center US Department of Agriculture Wake Forest Medical School Barcelona Science Park, Spain Keio University Medical School, Japan McMaster University, Canada Queensland Institute of Medical Research, Australia Tel Aviv University, Israel Examples of research topics using MSI instrumentation: TBI, MS, Parkinson’s disease, Huntington’s disease, epilepsy, ALS, Marfan Syndrome, muscular dystrophy, myocarditis, arthritis, drug abuse, drug toxicity, Down Syndrome, hyperthyroidism, myocardial dysfunction, and autism.
See moreLatest activity
Latest activity from Mouse Specifics, Inc.
3 signals
Research & Knowledge
Mouse Specifics, Inc. collaborated with Fralin Biomedical Research Institute at VTC to develop XOlacta, an oral milk extracellular vesicle formulation.
Research & Knowledge
Mouse Specifics, Inc. published a study examining how pediatric glioblastoma affects the growth and function of the developing musculoskeletal system in mouse models.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
GemPharmatech
GemPharmatech established and developed the DIO mouse model (Strain No. 𝗧𝟬𝟬𝟮𝟬𝟰𝟬) through 60 kcal% high-fat diet feeding to evaluate weight-loss efficacy and metabolic outcomes.
Products & Services
The Jackson Laboratory
The Jackson Laboratory provides Reference Posters for Mouse Model appearance by age, how to identify their sex, and other animal care and handling information.
Research & Knowledge
Quantum Innovations
Quantum Innovations developed Quantum Sense, a technology that records electrical activity directly from the epicardial surface of the beating heart to support myocardial ischaemia identification during OPCAB surgery.
Research & Knowledge
Biochrom Ltd.
Biochrom Ltd. published a new protocol for generating endothelial cell-specific knockout mice using CRISPR/Cas9 in STAR Protocols, reporting 84–90% editing efficiency and quantification using the BioDrop microvolume spectrophotometer.
Research & Knowledge
Microbiologics